financetom
Business
financetom
/
Business
/
Nordson to Buy Atrion for $460 per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nordson to Buy Atrion for $460 per Share
May 28, 2024 5:05 AM

07:37 AM EDT, 05/28/2024 (MT Newswires) -- Nordson ( NDSN ) said Tuesday it has agreed to buy Atrion ( ATRI ) for $460 per share in cash, representing an enterprise value of roughly $800 million.

The company, which plans to finance the transaction through cash on hand and newly issued financial debt, said it expects deal completion before its fiscal 2024 ends.

Nordson's ( NDSN ) shares were marginally higher in recent Tuesday premarket activity, while Atrion's ( ATRI ) stock was up 4.1%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Arthur J. Gallagher Buys Sheila J. Butler & Co.
Dec 11, 2024
09:34 AM EST, 12/11/2024 (MT Newswires) -- Arthur J. Gallagher ( AJG ) said Wednesday it has bought Georgia-based employee benefits brokerage firm Sheila J. Butler & Co. Financial terms weren't disclosed. Price: 284.17, Change: +0.43, Percent Change: +0.15 ...
Marchex Joining Microsoft's Cloud AI Partner Program
Marchex Joining Microsoft's Cloud AI Partner Program
Dec 11, 2024
09:33 AM EST, 12/11/2024 (MT Newswires) -- Marchex ( MCHX ) said Wednesday it has signed an agreement to join Microsoft's ( MSFT ) Cloud AI Partner Program. The move will give Marchex ( MCHX ) the ability to transact via Microsoft's ( MSFT ) Azure Marketplace, which will connect clients to its products, the company said. The products will...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely detailed plans...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved